Concepedia

Jennifer Doss

JD

Statistics

Publications

10

Citations

862

H-Index

10

Active since

2008

Affiliations

Institut Gustave Roussy(Current)

Memorial Sloan Kettering Cancer Center

Duke University

Queen Mary University of London

Dana-Farber Cancer Institute

Jennifer Doss is an author at Institut Gustave Roussy specializing in medicine, atezolizumab therapy, and pharmacology.

Publications per year

2008–2022

10

Publications

10

Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial

Thomas Powles, Kobe Yuen, Silke Gillessen et al. · Nature Medicine · 2022 · 242 citations · Full text

, , +16

A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes

Jennifer Doss, David L. Corcoran, Dereje D. Jima et al. · BMC Genomics · 2015 · 128 citations · Full text

, , +16

Iron-Responsive miR-485-3p Regulates Cellular Iron Homeostasis by Targeting Ferroportin

Carolyn Sangokoya, Jennifer Doss, Jen‐Tsan Chi · PLoS Genetics · 2013 · 122 citations · Full text

, , +17

Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis

Jessica J. Connelly, Jennifer Doss, Themistoclis Karaoli et al. · Human Molecular Genetics · 2013 · 89 citations · Full text

, , +14

Molecular correlates differentiate response to atezolizumab (atezo) + bevacizumab (bev) vs sunitinib (sun): Results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma (mRCC)

Brian I. Rini, Mahrukh Huseni, Michael B. Atkins et al. · Annals of Oncology · 2018 · 72 citations

, , +15

1–5 of 10